Status:
COMPLETED
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the image quality and clinical feasibility of double low-dose liver computed tomography using a deep-learning-based iodine contrast boosting algorithm in pa...
Detailed Description
The purpose of this study is to investigate the image quality (CNR, subjective inage quality, vessel and lesion conspicuity) and clinical feasibility (rate of lesion detection) of double low-dose live...
Eligibility Criteria
Inclusion
- Liver cirrhosis
- Tumor marker (aFP, PIVKA) elevation
- Nodular lesion on USG
- Received RFA for HCC
Exclusion
- hypersensitivity at iodine
- GFR under 30
- BMI over 30
- Nursing or pregnant women
- enrolled the other study
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04722120
Start Date
June 1 2016
End Date
January 1 2021
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea